Antigen presentation and T-cell activation are critical for RBP4-induced insulin resistance

Diabetes

Volumn 65, Issue 5, 2016, Pages 1317-1327

  Moraes Vieira, Pedro M ^a   Castoldi, Angela ^a   Aryal, Pratik ^a   Wellenstein, Kerry ^a   Peroni, Odile D ^a   Kahn, Barbara B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; CD4 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; RETINOL BINDING PROTEIN 4; TUMOR NECROSIS FACTOR; MYD88 PROTEIN, MOUSE; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GLUCOSE INTOLERANCE; INNATE IMMUNITY; INSULIN RESISTANCE; INSULIN SENSITIVITY; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; ADIPOSE TISSUE; ADVERSE EFFECTS; ANIMAL; ANTIGEN PRESENTING CELL; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; COCULTURE; GENETICS; HETEROZYGOTE; IMMUNOLOGY; KNOCKOUT MOUSE; LIPID DIET; LYMPHOCYTE ACTIVATION; MACROPHAGE; METABOLISM; OBESITY; PATHOLOGY; SPLEEN;

ADAPTIVE IMMUNITY; ADIPOSE TISSUE; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; BONE MARROW CELLS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COCULTURE TECHNIQUES; DIET, HIGH-FAT; GLUCOSE INTOLERANCE; HETEROZYGOTE; INSULIN RESISTANCE; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; OBESITY; RETINOL-BINDING PROTEINS, PLASMA; SPLEEN;

EID: 84964573504     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-1696     Document Type: Article

References (51)

1. Andrade-Oliveira V, Camara NO, Moraes-Vieira PM: Adipokines as drug targets in diabetes and underlying disturbances. J Diabetes Res 2015;2015:681612
2. Aeberli I, Biebinger R, Lehmann R, L'allemand D, Spinas GA, Zimmermann MB. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J Clin Endocrinol Metab 2007;92:4359-4365
3. Graham TE, Yang Q, Blüher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-2563
4. Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-362
5. Faghihi T, Radfar M, Abdoli E, Amini H, Hemami MR, Larijani B. Association of serum retinol-binding protein 4 with insulin resistance and metabolic parameters during olanzapine therapy. Clin Endocrinol (Oxf) 2012;76:207-211
6. Sun Q, Kiernan UA, Shi L, et al. Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the nurses' health study. Circulation 2013;127:1938-1947
7. Meisinger C, Rückert IM, Rathmann W, et al. Retinol-binding protein 4 is associated with prediabetes in adults from the general population: the Cooperative Health Research in the Region of Augsburg (KORA) F4 Study. Diabetes Care 2011;34:1648-1650
8. Qi Q, Yu Z, Ye X, et al. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 2007;92:4827-4834
9. Moraes-Vieira PM, Yore MM, Dwyer PM, Syed I, Aryal P, Kahn BB. RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance. Cell Metab 2014;19:512-526
10. Preitner F, Mody N, Graham TE, Peroni OD, Kahn BB. Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis. Am J Physiol Endocrinol Metab 2009;297:E1420-E1429
11. Munkhtulga L, Nagashima S, Nakayama K, et al. Regulatory SNP in the RBP4 gene modified the expression in adipocytes and associated with BMI. Obesity (Silver Spring) 2010;18:1006-1014
12. van Hoek M, Dehghan A, Zillikens MC, Hofman A, Witteman JC, Sijbrands EJ. An RBP4 promoter polymorphism increases risk of type 2 diabetes. Diabetologia 2008;51:1423-1428
13. Moraes-Vieira PM, Bassi EJ, Araujo RC, Câmara NO. Leptin as a link between the immune system and kidney-related diseases: leading actor or just a coadjuvant? Obes Rev 2012;13:733-743
14. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219-246
15. Balagopal P, Graham TE, Kahn BB, Altomare A, Funanage V, George D. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 2007;92:1971-1974
16. Yao-Borengasser A, Varma V, Bodles AM, et al. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 2007;92:2590-2597
17. Norseen J, Hosooka T, Hammarstedt A, et al. Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun. N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism. Mol Cell Biol 2012;32:2010-2019
18. Brestoff JR, Artis D. Immune regulation of metabolic homeostasis in health and disease. Cell 2015;161:146-160
19. Lumeng CN, Del Proposto JB, Westcott DJ, Saltiel AR. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 2008;57:3239-3246
20. Odegaard JI, Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 2013;339:172-177
21. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808
22. Morris DL, Cho KW, Delproposto JL, et al. Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice. Diabetes 2013;62:2762-2772
23. Stolarczyk E, Lord GM, Howard JK. The immune cell transcription factor T-bet: A novel metabolic regulator. Adipocyte 2014;3:58-62
24. Cho KW, Morris DL, DelProposto JL, et al. An MHC II-dependent activation loop between adipose tissue macrophages and CD4+ T cells controls obesityinduced inflammation. Cell Reports 2014;9:605-617
25. Han MS, Jung DY, Morel C, et al. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 2013;339:218-222
26. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007;56:16-23
27. Cutolo M, Nadler SG. Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis. Autoimmun Rev 2013;12:758-767
28. Xing H, Northrop JP, Grove JR, Kilpatrick KE, Su JL, Ringold GM. TNF alphamediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARgamma without effects on Pref-1 expression. Endocrinology 1997;138:2776-2783
29. Xu H, Sethi JK, Hotamisligil GS. Transmembrane tumor necrosis factor (TNF)-alpha inhibits adipocyte differentiation by selectively activating TNF receptor 1. J Biol Chem 1999;274:26287-26295
30. Nov. O, Shapiro H, Ovadia H, et al. Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability. PLoS One 2013;8:e53626
31. Todoric J, Strobl B, Jais A, et al. Cross-talk between interferon-γ and hedgehog signaling regulates adipogenesis. Diabetes 2011;60:1668-1676
32. Roche PA, Furuta K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol 2015;15:203-216
33. Macián F, Im SH, García-Cózar FJ, Rao A. T-cell anergy. Curr Opin Immunol 2004;16:209-216
34. Deng T, Lyon CJ, Minze LJ, et al. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab 2013;17:411-422
35. Chatzigeorgiou A, Chung KJ, Garcia-Martin R, et al. Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation. Hepatology 2014;60:1196-1210
36. Castoldi A, Naffah de Souza C, Câmara NO, Moraes-Vieira PM. The Macrophage Switch in Obesity Development. Front Immunol 2015;6:637
37. Weisman MH, Durez P, Hallegua D, et al. Reduction of inflammatory biomarker response by abatacept in treatment of rheumatoid arthritis. J Rheumatol 2006;33:2162-2166
38. Satyananda V, Shapiro R. Belatacept in kidney transplantation. Curr Opin Organ Transplant 2014;19:573-577
39. Ursini F, Russo E, Letizia Hribal M, et al. Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study. Medicine (Baltimore) 2015;94:e888
40. Ursini F, Mauro D, Naty S, Gagliardi D, Grembiale RD. Improvement in insulin resistance after short-term treatment with abatacept: case report and short review. Clin Rheumatol 2012;31:1401-1402
41. Jialal I, Kaur H, Devaraj S. Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. J Clin Endocrinol Metab 2014;99:39-48
42. Prajapati B, Jena PK, Rajput P, Purandhar K, Seshadri S. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes. Curr Diabetes Rev 2014;10:190-200
43. Yang H, Youm YH, Vandanmagsar B, et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol 2010;185:1836-1845
44. Strissel KJ, DeFuria J, Shaul ME, Bennett G, Greenberg AS, Obin MS. T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring) 2010;18:1918-1925
45. Winer S, Chan Y, Paltser G, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009;15:921-929
46. Quadro L, Blaner WS, Hamberger L, et al. Muscle expression of human retinol-binding protein (RBP). Suppression of the visual defect of RBP knockout mice. J Biol Chem 2002;277:30191-30197
47. Nguyen MT, Favelyukis S, Nguyen AK, et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 2007;282:35279-35292
48. Zemany L, Bhanot S, Peroni OD, et al. Transthyretin antisense oligonucleotides lower circulating RBP4 levels and improve insulin sensitivity in obese mice. Diabetes 2015;64:1603-1614
49. Zemany L, Kraus BJ, Norseen J, et al. Downregulation of STRA6 in adipocytes and adipose stromovascular fraction in obesity and effects of adipocytespecific STRA6 knockdown in vivo. Mol Cell Biol 2014;34:1170-1186
50. Moraes-Vieira PM, Larocca RA, Bassi EJ, et al. Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells. Eur J Immunol 2014;44:794-806
51. Moraes-Vieira PM, Bassi EJ, Larocca RA, et al. Leptin deficiency modulates allograft survival by favoring a Th2 and a regulatory immune profile. [corrected]. Am J Transplant 2013;13:36-44